Companies / HPC

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED

ASX:HPCHousehold & Personal Products
538.0M shares on issueASX (delayed) · as of 28 July 2026$0.004price · delayed$2.2Mmarket cap · indicative
F
Dilution grade

Runway under 2 quarters; share count grew 73% in 24 months; 4 cash raises in 24 months

Cash runway0.2 quarters of funding
Share-count growth (24m)73.4%
Raise cadence (24m)4 cash raises
Options & rights overhang26.1% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

THE HYDRATION PHARMACEUTICALS COMPANY LIMITED's ordinary share count grew 73.4% between May 2024 and June 2026, to 529M shares. The company completed four capital raises in that period for total proceeds of A$1.7M, most recently a A$392K placement in June 2026. Options and rights on issue could convert into 140M new shares, equal to 26.1% of the current share count, with 0% in the money at present and the nearest expiry in December 2026. At the March 2026 quarter the company reported A$105K in cash, representing 0.2 quarters of cover. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
26.1%
Max option dilution
0.0%
ITM option dilution
1
Raises · last 12 months
0.2 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 538.0M per ASX (delayed) (28 July 2026).
353.9M421.5M489.0MDec 24Sept 25July 26Cash raise · 11 June 2026Cash raise · 8 July 2025Cash raise · 19 Mar 2025Cash raise · 18 Mar 2025

Cash runway

0.2 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$105k available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
22 June 20262A · quoted issueHPC : ORDINARY FULLY PAID440.0MAppendix 2A
22 June 20262A · quoted issueHPC : ORDINARY FULLY PAID528.8MAppendix 2A
7 Jan 20263H · cancellationHPC : ORDINARY FULLY PAID430.8MAppendix 3H
6 Oct 20253H · cancellationHPC : ORDINARY FULLY PAID430.8MAppendix 3H
10 July 20252A · quoted issueHPC : ORDINARY FULLY PAID430.8MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

4 cash raises in the last 24 months · 1 in the last 12 months

$392k
Placement
11 June 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

26.1%
Total overhang · of current shares
0.0%
In the money · at current price
140.5M
Potential new shares
Dec 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
31 Dec 2025Nicholas BerrySell73.1M52.4M3Y notice
31 Dec 2025Adem KarafiliSell2.6M75k3Y notice
31 Dec 2025Margaret HardinSell372k54k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.